May 30 - June 2, 2007
Hyatt Regency Tamaya
Santa Ana Pueblo, New Mexico
Alisa M. Goldstein, National Cancer Institute, Bethesda, MD
David J. Hunter, Harvard University, Boston, MA
Thomas A. Sellers, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Duncan C. Thomas, University of Southern California, Los Angeles, CA
This AACR Special Conference in Cancer Research was organized in conjunction with the Molecular Epidemiology Working Group of the AACR (MEG). MEG promotes the incorporation of molecular and biochemical concepts and techniques into well-designed epidemiologic studies.
The conference provided examples of pathway driven research to illustrate how inherited variation at each step of a biological pathway informs the exploration of candidate gene associations with disease risk. Novel biological opportunities from animal models, gene expression, proteomics, computational biology, functional and evolutionary conservation, and epigenetics were presented, along with new developments in study designs and statistical analyses that incorporate biology in their approaches. The conference included cancer biologists, epidemiologists, geneticists, statisticians and others, allowing for discussion about methodologies and approaches to address these new challenges.
Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.